Impaired cardiac muscarinic receptor function in dogs with heart failure.
Open Access
- 1 June 1988
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 81 (6), 1836-1842
- https://doi.org/10.1172/jci113528
Abstract
Prior physiological studies have suggested that parasympathetic control is altered in heart failure. The goal of our studies was to investigate the influence of heart failure on the muscarinic receptor, and its coupling to adenylate cyclase. Ligand binding studies using [3H]quinuclidinyl benzilate and enriched left ventricular (LV) sarcolemma, demonstrated that muscarinic receptor density in heart failure declined 36% from a control of 5.6 .+-. 0.6 pmol/mg, with no change in antagonist affinity. However, agonist competition studies with both carbachol and oxotremorine showed that it was a loss of high affinity agonist binding sites in the sarcolemma from failing LV that accounted for this difference. The functional efficacy of the muscarinic receptor was also examined. When 1 .mu.M methacholine was added to 0.1 mM GTP and 0.1 mM isoproterenol, adenylate cyclase stimulated activity was inhibited by 15% in normal LV but only 5% in LV sarcolema from animals with heart failure even when the reduced adenylate cyclase in these heart failure animals was taken into account. Even at 100-fold greater concentrations of methacholine, significantly less inhibition of adenylate cyclase activity was observed in LV failure as compared with normal LV sarcolemma. Levels of the GTP-inhibitory protein known to couple the muscarinic receptor to adenylate cyclase, as measured with pertussis toxin labeling, were not depressed in LV failure. Thus, the inhibitory pathway regulating LV adenylate cyclase activity is defective in heart failure. The decrease in muscarinic receptor density, and in particular the specific loss of the high affinity agonist binding component of this receptor population, appears to be the major factor underlying this abnormality.This publication has 28 references indexed in Scilit:
- Protein kinase C phosphorylates the inhibitory guanine‐nucleotide‐binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclaseEuropean Journal of Biochemistry, 1985
- Mechanisms of supersensitivity to sympathomimetic amines in the chronically denervated heart of the conscious dog.Circulation Research, 1985
- Reconstitution of resolved muscarinic cholinergic receptors with purified GTP-binding proteins.Journal of Biological Chemistry, 1985
- Purification and properties of the inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase.Journal of Biological Chemistry, 1984
- Guanine nucleotide-binding regulatory proteins and dual control of adenylate cyclase.Journal of Clinical Investigation, 1984
- Reciprocal modulation of agonist and antagonist binding to muscarinic cholinergic receptor by guanine nucleotide.Proceedings of the National Academy of Sciences, 1982
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980
- The character of the muscarinic receptors in different regions of the rat brainProceedings of the Royal Society of London. B. Biological Sciences, 1980
- Muscarinic cholinergic receptor modulation of beta-adrenergic receptor affinity for catecholamines.Journal of Biological Chemistry, 1978
- Presynaptic muscarinic cholinergic receptorsNature, 1978